RI2A Intrinsic Valuation and Fundamental Analysis - Rigel Pharmaceuticals Inc

R	Rigel Pharmaceuticals Inc SWB:RI2A	US
	AXA SA MIL:1CS	FR

Intrinsic Value

The intrinsic value for Rigel Pharmaceuticals Inc (RI2A) under the Base Case is 7.136 EUR. Compared with the current market price of 7.345 EUR, the stock appears Overvalued by 3% .

Intrinsic value calculated as an equal blend of DCF

€6.032

and Multiples

€8.239

Other reference points

Wall St target

€10.021

Do our valuations actually work? See backtest results .

RI2A Intrinsic Value

Overvaluation 3%

Intrinsic Value

Price €7.345

Track Buy Zone

20% below Intrinsic Value €5.71

Get notified when the price drops into your buy zone

Current Price €7.35

Intrinsic Value €7.14

Margin of Safety 20% €5.71

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Loading...

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Rigel Pharmaceuticals Inc.

Explain Valuation